The gut microbiome in human neurological disease: A review

@article{Tremlett2017TheGM,
  title={The gut microbiome in human neurological disease: A review},
  author={H. Tremlett and K. C. Bauer and S. Appel-Cresswell and B. Finlay and E. Waubant},
  journal={Annals of Neurology},
  year={2017},
  volume={81}
}
Almost half the cells and 1% of the unique genes found in our bodies are human, the rest are from microbes, predominantly bacteria, archaea, fungi, and viruses. These microorganisms collectively form the human microbiota, with most colonizing the gut. Recent technological advances, open access data libraries, and application of high‐throughput sequencing have allowed these microbes to be identified and their contribution to neurological health to be examined. Emerging evidence links… Expand

Paper Mentions

Interventional Clinical Trial
Given the role of adaptive immunity in ALS, the pathogenicity of some clostridial strains on motorneurons, the putative role of cyanobacteria in ALS development, and the increasing… Expand
ConditionsAmyotrophic Lateral Sclerosis
InterventionBiological
The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases
TLDR
The focus of this manuscript is to draw connection between the microbiota–gut–brain (MGB) axis, antibiotics and the use of “BUGS AS DRUGS” for neurodegenerative diseases, their treatment, diagnoses and management and to compare the effect of current and past pharmaceuticals and antibiotics for alternative mechanisms of action for brain and neuronal disorders. Expand
A Fungal World: Could the Gut Mycobiome Be Involved in Neurological Disease?
TLDR
An overview of recent advances in gut mycobiome research is provided and the plausible role of both intestinal and non-intestinal fungi in the context of neuroimmune and neurodegenerative conditions is discussed. Expand
The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
TLDR
Evidence indicates that changes in microbiota composition may result in imbalances that could result in disease, with the gut as a potential novel therapeutic avenue and targeting the gut microbiota may lead to the development of novel therapeutic strategies. Expand
Gut microbiome and pediatric multiple sclerosis
TLDR
The overarching goal of this Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) presentation was to provide a high-level insight into gut microbiota’s potential role in pediatric MS. Expand
Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders
TLDR
A concise review of preclinical paradigms that involve immunologically–induced GI deficits and dysbiosis of maternal microflora that are functionally linked to impaired neurodevelopmental processes leading to affective behavioral syndromes in the offspring is included. Expand
Human microbiome diversity: implications in health, disease, and applications
TLDR
For the full impact of the various applications (both, potentials and current) of human microbiome to be felt, there is a need for more studies that will fully elucidate their physiology in humans. Expand
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
TLDR
A review explores alterations to gut microbiota, correlations with clinical manifestations of PD, and briefly probes the underlying mechanisms as well as the highly controversial roles of microbial metabolites. Expand
Multiple sclerosis: Possibility of a gut environment-induced disease
TLDR
The potential role of diet in the development of MS and a hypothesis that could explain the dramatic increase in the number of patients suffering with MS in Japan in the past few decades are discussed. Expand
“I Am I and My Bacterial Circumstances”: Linking Gut Microbiome, Neurodevelopment, and Depression
TLDR
The role played by the gut microbiome in neurodevelopment and in the etiology of the depressive syndrome is explored, including nutritional, immunological, and energy homeostasis approaches. Expand
Microbiota’s role in health and diseases
TLDR
Evidence from the most recent works and suggested nutraceutical approaches for the management of COVID-19 pandemic are brought together and the role of the microbiome in health and disease is discussed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 147 REFERENCES
The role of microbiome in central nervous system disorders
TLDR
Research on the role of microbiome in CNS disorders deepens academic knowledge about host-microbiome commensalism in central regulation and in practicality holds conceivable promise for developing novel prognostic and therapeutic avenues for CNS disorders. Expand
The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease.
TLDR
For a subset of AD patients, aging favors the overgrowth of oral anaerobes established earlier in life provoking a pro-inflammatory innate response that weakens the BBB allowing bacteria to spread and quietly influence the pathogenesis of AD. Expand
Gut microbiota are related to Parkinson's disease and clinical phenotype
TLDR
The findings suggest that the intestinal microbiome is altered in PD and is related to motor phenotype, and the suitability of the microbiome as a biomarker is warranted. Expand
Alterations of the human gut microbiome in multiple sclerosis
TLDR
Microbiome alterations in MS include increases in Methanobrevibacter and Akkermansia and decreases in Butyricimonas and correlate with variations in the expression of genes involved in dendritic cell maturation, interferon signalling and NF-kB signalling pathways in circulating T cells and monocytes. Expand
Multiple Sclerosis Lesions Show Perturbations in Cerebral Microbiota (S37.005)
TLDR
Overall microbiota abundance was low with restricted replication and dominated by alpha-proteobacteria in human brain white matter, which has important implications for the pathogenesis and clinical treatment trials of MS. Expand
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
TLDR
Analysis of the bacterial 16S ribosomal RNA (rRNA) gene by using a high-throughput culture-independent pyrosequencing method provided evidence of a moderate dysbiosis in the structure of gut microbiota in patients with MS, and phylogenetic tree analysis revealed that many of the clostridial species associated with MS might be distinct from those broadly associated with autoimmune conditions. Expand
Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model
TLDR
A potential novel role of the intestinal epithelium and microbiome in the progression of ALS is suggested and principal coordinate analysis indicated a difference in fecal microbial communities between ALS and wild‐type mice. Expand
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
TLDR
It is reported herein that gut microbiota are required for motor deficits, microglia activation, and αSyn pathology, and suggested that alterations in the human microbiome represent a risk factor for PD. Expand
Control of brain development, function, and behavior by the microbiome.
TLDR
Emerging evidence that the microbiome extends its influence to the brain via various pathways connecting the gut to the central nervous system is highlighted. Expand
The human microbiome project: exploring the microbial part of ourselves in a changing world
The human microbiome project (HMP) reflects the fact that we are supraorganisms composed of human and microbial components. This international effort emanates from a confluence of ongoing technicalExpand
...
1
2
3
4
5
...